IL1B and COVID-19: In line with these findings, our analyses demonstrated that inactivated SARS-CoV-2 effectively stimulates IL-1β production, TNF, and NLRP3 inflammasome formation, serving as a reliable model to replicate the inflammatory response observed in COVID-19 patients [28,29,30].